NO345064B1 - Anvendelse av kombinasjonslegemidler, omfattende antimykotika - Google Patents

Anvendelse av kombinasjonslegemidler, omfattende antimykotika

Info

Publication number
NO345064B1
NO345064B1 NO20180083A NO20180083A NO345064B1 NO 345064 B1 NO345064 B1 NO 345064B1 NO 20180083 A NO20180083 A NO 20180083A NO 20180083 A NO20180083 A NO 20180083A NO 345064 B1 NO345064 B1 NO 345064B1
Authority
NO
Norway
Prior art keywords
combination drugs
antifungals
including antifungals
drugs
combination
Prior art date
Application number
NO20180083A
Other languages
English (en)
Other versions
NO20180083A1 (no
Inventor
Christian Noe
Marion Noe-Letschnig
Original Assignee
Christian Noe
Noe Letschnig Marion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20180083A1 publication Critical patent/NO20180083A1/no
Application filed by Christian Noe, Noe Letschnig Marion filed Critical Christian Noe
Publication of NO345064B1 publication Critical patent/NO345064B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20180083A 2006-05-12 2018-01-18 Anvendelse av kombinasjonslegemidler, omfattende antimykotika NO345064B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT8262006 2006-05-12
PCT/AT2007/000227 WO2007131253A2 (de) 2006-05-12 2007-05-10 Verwendung von kombinationspräparaten, umfassend antimykotika

Publications (2)

Publication Number Publication Date
NO20180083A1 NO20180083A1 (no) 2009-02-10
NO345064B1 true NO345064B1 (no) 2020-09-14

Family

ID=37903545

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20085181A NO342103B1 (no) 2006-05-12 2008-12-11 Kombinasjonslegemiddel som inneholder et antimykotiskt middel og et ikke-steroid, antiinflammatorisk middel, for anvendelse ved topisk behandling av Candida-mykoser
NO20180083A NO345064B1 (no) 2006-05-12 2018-01-18 Anvendelse av kombinasjonslegemidler, omfattende antimykotika

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20085181A NO342103B1 (no) 2006-05-12 2008-12-11 Kombinasjonslegemiddel som inneholder et antimykotiskt middel og et ikke-steroid, antiinflammatorisk middel, for anvendelse ved topisk behandling av Candida-mykoser

Country Status (19)

Country Link
US (2) US8552042B2 (no)
EP (2) EP3192507B1 (no)
JP (1) JP2009536926A (no)
CN (1) CN101484162A (no)
AU (1) AU2007250502B2 (no)
CA (1) CA2651726C (no)
CY (1) CY1119094T1 (no)
DK (1) DK2018164T3 (no)
ES (1) ES2627268T3 (no)
HR (1) HRP20170793T1 (no)
HU (1) HUE033499T2 (no)
LT (1) LT2018164T (no)
NO (2) NO342103B1 (no)
PL (1) PL2018164T3 (no)
PT (1) PT2018164T (no)
RS (1) RS56044B1 (no)
RU (1) RU2008148977A (no)
SI (1) SI2018164T1 (no)
WO (1) WO2007131253A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI23311A (sl) * 2010-03-19 2011-09-30 Kemijski inštitut Farmacevtska kombinacija acetilsalicilne kisline in protiglivne substance za uničevanje ali inhibicijo rasti in replikacije gliv
CN102210649A (zh) * 2010-04-09 2011-10-12 上海医药科技发展有限公司 一种两性霉素b乳膏及其制备方法
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
CN103044408A (zh) * 2013-01-21 2013-04-17 万礼 在治疗恶性肿瘤时应用的伊曲康唑或其盐及其组合物
US8883747B1 (en) * 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
ES2794824T3 (es) * 2015-01-13 2020-11-19 Acraf Composición farmacéutica para el tratamiento de la micosis
CN104920360B (zh) * 2015-06-18 2017-04-12 青岛农业大学 丁苯羟酸在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的用途
EP3482744A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
EP3482743A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur behandlung von scheideninfektionen
AU2018367122A1 (en) 2017-11-14 2020-06-04 Profem Gmbh Emulsions for the topical treatment of dermal infections and mucosal infections
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
WO2023220224A1 (en) * 2022-05-12 2023-11-16 St. Jude Children's Research Hospital, Inc. Synergistic antifungal composition and method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017165A2 (en) * 1993-12-23 1995-06-29 The Procter & Gamble Company Tissue moisturizing and antimicrobial compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6471823A (en) * 1987-09-12 1989-03-16 Rohto Pharma Sustained remedy for vaginal candidiasis
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ES2079994B1 (es) 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
AU3372200A (en) * 1999-02-19 2000-09-04 Ligocyte Pharmaceuticals, Inc. Antibodies against hydrophobic proteins that are protective against candidiasis
DK1191939T3 (da) 1999-03-24 2008-02-11 Zengen Inc Antimikrobielle aminosyresekvenser afledt fra alfa-melanocytstimulerende hormon
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030181384A1 (en) 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20040142910A1 (en) * 2002-10-21 2004-07-22 Aegis Biosciences Llc Sulfonated styrene copolymers for medical uses
AU2003293529A1 (en) * 2002-12-16 2004-07-29 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
WO2005000287A1 (ja) 2003-06-25 2005-01-06 Hisamitsu Pharmaceutical Co., Inc. 水虫治療用外用剤
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
MXPA06013886A (es) * 2004-05-28 2007-01-26 Schering Corp Suspension farmaceutica inyectable que comprende posaconazol.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017165A2 (en) * 1993-12-23 1995-06-29 The Procter & Gamble Company Tissue moisturizing and antimicrobial compositions

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SCOTT E M ET AL, "Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 1995 UNITED STATES, (1995), vol. 39, no. 12, ISSN 0066-4804, pages 2610 - 2614, Dated: 01.01.0001 *
TARIQ V N ET AL, "Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, (199512), vol. 39, no. 12, ISSN 0066-4804, pages 2615 - 2619, Dated: 01.01.0001 *
YUCESOY M ET AL, "In-vitro synergistic effect of fluconazole with nonsteroidal anti-inflammatory agents against Candida albicans strains", JOURNAL OF CHEMOTHERAPY, (200010), vol. 12, no. 5, ISSN 1120-009X, pages 385 - 389, Dated: 01.01.0001 *

Also Published As

Publication number Publication date
CA2651726C (en) 2015-12-15
CN101484162A (zh) 2009-07-15
ES2627268T3 (es) 2017-07-27
EP3192507B1 (de) 2020-07-08
JP2009536926A (ja) 2009-10-22
SI2018164T1 (sl) 2017-07-31
CY1119094T1 (el) 2018-01-10
US8552042B2 (en) 2013-10-08
WO2007131253A3 (de) 2008-11-27
EP2018164A2 (de) 2009-01-28
DK2018164T3 (en) 2017-06-12
US8815925B2 (en) 2014-08-26
HUE033499T2 (en) 2017-12-28
NO20085181L (no) 2009-02-10
RS56044B1 (sr) 2017-09-29
AU2007250502B2 (en) 2013-11-28
CA2651726A1 (en) 2007-11-22
PL2018164T3 (pl) 2017-08-31
EP2018164B1 (de) 2017-03-01
RU2008148977A (ru) 2010-06-20
NO20180083A1 (no) 2009-02-10
HRP20170793T1 (hr) 2017-10-06
PT2018164T (pt) 2017-06-12
US20140030312A1 (en) 2014-01-30
LT2018164T (lt) 2017-07-10
WO2007131253A2 (de) 2007-11-22
EP3192507A1 (de) 2017-07-19
US20090208558A1 (en) 2009-08-20
NO342103B1 (no) 2018-03-26
AU2007250502A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
NO345064B1 (no) Anvendelse av kombinasjonslegemidler, omfattende antimykotika
LTPA2018006I1 (lt) Pakeistųjų oksazolidinonų kombinuota terapija
BRPI0815773A2 (pt) composto, e, medicamento.
ATE467633T1 (de) 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
NL2000480A1 (nl) Nieuwe farmaceutische middelen.
CL2007002783S1 (es) Inhalador multidosis.
DE602007010981D1 (de) Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate
NL2000627A1 (nl) Cycloalkylaminoderivaten.
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
DK2117521T3 (da) Transdermale indgivelsessystemer omfattende bupivacain
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DK2035369T3 (da) Terapeutiske
BRPI0814736A2 (pt) inalador.
DK2046802T3 (da) 2-substituerede methylpenamderivater
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
ATE544764T1 (de) 5-hydroxymethyloxazolidin-2-onderivate
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0819202A2 (pt) Derivado heterocíclico, e, composição farmacêutica
NO20083139L (no) Anvendelse av hyllebærekstrakt
BRPI0922888A2 (pt) administração combinada de fármaco
FR2917418B1 (fr) Composition de securite, non photocopiable et authentifiable
ATE519751T1 (de) Dihydro-benzoäbüä1,4üdiazepin-2-on- sulfonamidderivate